| 영문 | Hodgkin's disease | 한글 | 호지킨병 |
|---|---|---|---|
| 설명 | 악성림프종의 한 형태이다. 호지킨병은 방사선 치료에 대단히 예민해서 충분한 양의 방사선으로 완전한 근치적 치료가 가능하다. |
||
| 영문 | non-Hodgkin lymphoma | 한글 | 비호지킨 림프종 |
|---|---|---|---|
| 설명 | 림프종은 림프절에 생긴 악성 종양으로 백혈병과는 다르다. 백혈병은 골수에서 생긴 림프구성 악성종양이지만, 림프종은 림프조직에서 생긴 림프구성 악성종양이다. 크게 림프종은 2가지로 나눌 수 있는 데, 호지킨병(Hodgkin's lymphoma)과 비호지킨림프종(non-Hodgkin's lymphoma)으로 나눌 수 있다. 또한 비호지킨림프종은 여러 가지의 세포형태에 따라 나누고 있다. 이 병은 단지 림프절뿐만 아니라 지라, 골수, 이외 다른 기관을 침범함으로써 악성이며, 생명에 큰 위협을 준다. 악성림프종의 일종. 전이의 형태가 다양하여, 주위 림프절을 건너뛰어 다른 림프절로 전이하기도 한다. 또한 세포의 형태에 따라 여러 가지 종류가 있으며 대개 치료는 방사선치료와 화학요법을 복합하여 사용한다. |
||
| 영문 | ovarian cancer | 한글 | 난소암 |
|---|---|---|---|
| 설명 | 여성의 난소에 발생하는 암. 부인과종양으로서 50세 이상 여성악성종양의 약 18%를 차지한다. 종양은 대개 복부 깊숙히 위치하므로 종양이 많이 진행된 상태에서 발견되는 수가 많으며, 또한 종양의 초기에는 증상이 거의 없는 경우가 많아 더욱 조기발견이 어렵다. 아주 다양한 종류의 암이 발생하며, 예후도 각기 그 종양의 종류에 따라 다르다. 대표적인 암으로 장성낭샘암종(serous cystadenocarcinoma), 점액낭샘암종(mucinous cystadenocarcinoma), 종자세포종(germinoma 등이 있다. 치료는 수술적 치료가 선행되어야 하지만, 많이 진행되어 이미 다른 조직으로 전이가 이루어진 상태에서는 화학요법이 선택적으로 사용된다. |
||
| 영문 | cancer | 한글 | 암 |
|---|---|---|---|
| 설명 | 끝없이 분열을 하여 혈액이나 림프관을 통하여 다른 장기에까지 전파될 수 있는 세포의 덩어리. 즉 악성 신생물을 말한다. 신생물은 악성과 양성이 있는데, 악성일 경우에는 성장이 매우 빠르고 혈액이나 림프관을 통해서 멀리 다른 떨어진 장기로 암세포의 전파가 가능하여 다른 장기에도 암을 전이하며, 양성은 천천히 자라고 다른곳으로 전이가 생기지 않는다. 암은 암종과 육종의 두 가지로 나눌 수가 있다. 암종이란 상피세포의 과도한 증식에 의한 악성신생물을 이르는 말이고 육종이란 비상피성세포 특히 중간엽세포(발생당시에 중간엽에 해당하는 조직으로 발생후에 조직사이에 분포하면서 조직을 지지하는 역할을 하는 결합조직, 혈관, 림프관 등이 된다)의 과도한 증식에 의한 악성 신생물을 이르는 말이다. |
||
| 영문 | cancer surgery | 한글 | 암 수술 |
|---|---|---|---|
| 설명 | 암의 4대 치료법은 외과적 수술요법, 방사선 치료법, 항암 화학요법, 면역요법 등을 말하며 이중 수술요법과 방사선 요법은 국소적 요법으로서 암세포가 원발장기(처음 암이 발생한 장기)나 국소 림프절까지 국한되어 있는 제 1, 2기 암의 치료에 사용된다. 화학요법과 면역요법은 전신요법으로서 제 3, 4기 암에 주로 사용되며, 1, 2기 암의 치료 후 눈에 보이지 않게 남아 있을 수 있는 잔류암세포나 미세전이 암세포의 완전파괴, 사멸을 위해 사용된다. 백혈병, 림프종과 같이 화학요법제에 잘 듣는 혈액암, 림프종과 고환종과 같이 방사선 치료에 잘 듣는 암을 제외한 대부분의 고형암(solid tumor)인 위창자관암, 간암, 이자암, 유방암, 갑상샘암, 폐암, 흑색종, 연조직암, 뼈육종, 침샘암 등은 모두 수술요법으로 치료하여야 한다. 암수술의 기본원칙: 암수술의 3가지 기본요건은 안전성, 근치성, 기능보존성이며 암수술시에는 암병터를 되도록 조심해서 적게 만지면서 수술하고 암병터를 공급하는 동정맥과 림프관을 먼저 결찰하여 암병터가 퍼지는 것을 방지한다. 암수술의 목표는 근치적 절제수술(radical surgery)이다. 그러나 이것이 불가능한 환자에서는 출혈, 폐색, 천공 등의 합병증이 발생했을때 구급목적으로 혹은 지속적 동통이 있을때 생활내용의 질적 개선을 위하여 고식적 수술(palliative surgery)을 한다. 그리고 암의 정확한 진단과 진행도의 결정을 위한 진단적 수술(diagnostic surgery)이 있다. |
||
| HD | Haab-Dimmer [syndrome]; Hajna-Damon [broth]; Hansen disease; hearing distance; heart disease; helix ... |
|---|---|
| AFP | Alpha(α) Feto-Protein [HP 1826, 1858, 1859, 2265] ; Oncofetal Antigens &nbs... |
| CD | cadaver donor; canine distemper; canine dose; carbohydrate dehydratase; carbon dioxide; cardiac dise... |
| MD | Doctor of Medicine [Lat. Medicinae Doctor]; magnesium deficiency; main duct; maintenance dose; major... |
| CEA | Carcino-Embryonic Antigen [HP 1825-6] ; Oncofetal Antigens ; Glycopro... |
| HD | HODGKIN'S DISEASE |
|---|---|
| LPHD | Lymphocyte predominance Hodgkin's disease |
| LPHD | lymphocyte predominant Hodgkin Disease |
| NLPHD | Nodular lymphocyte predominance Hodgkin's disease |
| CHD | classical Hodgkin disease |
| cancer, hodgkin's disease | A type of lymphoma (cancer of the lymphatic system). The most common symptom of Hodgkin's disease is a painless swelling in the lymph nodes in the neck, underarm, or groin. Hodgkin's disease is diagnosed when abnormal tissue is detected by a pathologist after a biopsy of an enlarged lymph node. Treatment usually includes radiation therapy or chemotherapy. Regular follow-up examinations are important after treatment for Hodgkin's disease. Patients treated for Hodgkin's disease have an increased risk of developing other types of cancer later in life, especially leukaemia. (12 Dec 1998) |
|---|---|
| cancer, lymphoma, hodgkin's | A type of lymphoma (cancer of the lymphatic system). The most common symptom of Hodgkin's disease is a painless swelling in the lymph nodes in the neck, underarm, or groin. Hodgkin's disease is diagnosed when abnormal tissue is detected by a pathologist after a biopsy of an enlarged lymph node. Treatment usually includes radiation therapy or chemotherapy. Regular follow-up examinations are important after treatment for Hodgkin's disease. Patients treated for Hodgkin's disease have an increased risk of developing other types of cancer later in life, especially leukaemia. (12 Dec 1998) |
| cancer, lymphoma, non-hodgkin's | A lymphoma is a cancer that develops in the lymphatic system. The most common symptom of non-Hodgkin's lymphomas is a painless swelling in the lymph nodes in the neck, underarm, or groin. Non-Hodgkin's lymphomas are diagnosed with a biopsy of an enlarged lymph node. Follow-up examinations are important after lymphoma treatment. Most relapses occur in the first 2 years after therapy. (12 Dec 1998) |
| Hodgkin's disease | <haematology, oncology> A human malgnant disorder of lymph tissue (lymphoma) that appears to originate in a particular lymph node and later spreads to the spleen, liver and bone marrow. It occurs mostly in individuals between the ages of 15 and 35. It is characterised by progressive, painless enlargement of the lymph nodes, spleen and general lymph tissue. Giant cells, the Reed Sternberg cells, with mirror image nuclei are diagnostic. Immunological depletion, caused perhaps by the excessive growth of neoplastic histiocytes, occurs. Four types of the disease are recognised depending on the relative predominance of various neoplastic derivatives of the lymphoid series. Pyrexia is often a feature of the disease. Death often results from generalised immunological inability to respond to infections. If detected early, it has a high remission rate. Staging: Ann Arbor classification; each stage is further classified as:, A no symptoms, B fever, sweats, weight loss. Stage I - involvement of a single lymph-node region or extralymphatic site. Stage II - two or more sites of involvement on the same side of the diaphragm. Stage III - disease involvement on both sides of the diaphragm. Stage IV - disseminated disease of extralymphatic organs, with or without lymph-node involvement. Indicence: approximately 1,500 new cases per year in the UK. (30 Mar 2000) |
| disease, hodgkin's | A type of lymphoma (cancer of the lymphatic system). The most common symptom is painless swelling of the lymph nodes in the neck, underarm, or groin. Hodgkin's disease is diagnosed when abnormal tissue is detected by a pathologist after a biopsy of an enlarged lymph node. Treatment usually includes radiation therapy or chemotherapy. Regular follow-up examinations are important after treatment. Patients treated for Hodgkin's disease have an increased risk of developing other types of cancer later in life, especially leukaemia. A disease of the lymph nodes named after the English physician Thomas Hodgkin (1798-1866) who discovered it. (12 Dec 1998) |
| Goldman-Hodgkin-Katz equation | An equation derived to predict membrane potentials in terms of the membrane's permeability to ions and their concentrations on either side. Synonym: constant field equation, Goldman-Hodgkin-Katz equation, GHK equation. (05 Mar 2000) |
| Hodgkin, Alan | <person> British physiologist and Nobel laureate, *1914. See: Goldman-Hodgkin-Katz equation. (05 Mar 2000) |
| Hodgkin-Key murmur | <cardiology, clinical sign> A musical diastolic murmur associated with retroversion of an aortic cusp; often very loud. (05 Mar 2000) |
| Hodgkin's lymphoma | <haematology, oncology> A human malgnant disorder of lymph tissue (lymphoma) that appears to originate in a particular lymph node and later spreads to the spleen, liver and bone marrow. It occurs mostly in individuals between the ages of 15 and 35. It is characterised by progressive, painless enlargement of the lymph nodes, spleen and general lymph tissue. Giant cells, the Reed Sternberg cells, with mirror image nuclei are diagnostic. Immunological depletion, caused perhaps by the excessive growth of neoplastic histiocytes, occurs. Four types of the disease are recognised depending on the relative predominance of various neoplastic derivatives of the lymphoid series. Pyrexia is often a feature of the disease. Death often results from generalised immunological inability to respond to infections. If detected early, it has a high remission rate. Staging: Ann Arbor classification; each stage is further classified as:, A no symptoms, B fever, sweats, weight loss. Stage I - involvement of a single lymph-node region or extralymphatic site. Stage II - two or more sites of involvement on the same side of the diaphragm. Stage III - disease involvement on both sides of the diaphragm. Stage IV - disseminated disease of extralymphatic organs, with or without lymph-node involvement. Indicence: approximately 1,500 new cases per year in the UK. (30 Mar 2000) |
| Hodgkin, Thomas | <person> British physician, 1798-1866. See: Hodgkin's disease, Hodgkin-Key murmur, non-Hodgkin's lymphoma. (05 Mar 2000) |
| non-Hodgkin's lymphoma | <oncology, tumour> A group of lymphomas which differ in important ways from Hodgkin's disease and are classified according to the microscopic appearance of the cancer cells. The disease is classified as either low grade (slowly growing), intermediate grade or high grade (rapidly growing) and may be treated in a variety of ways depending on the exact diagnosis. Previously called lymphosarcoma. (30 Sep 1997) |
| lymphoma, non-hodgkin | Any of a group of malignant tumours of lymphoid tissue that differ from hodgkin disease, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumours is the absence of giant reed-sternberg cells, a characteristic of hodgkin's disease. (12 Dec 1998) |
| American Cancer Society | <address, organisation> American Cancer Society, National Headquarters, 1599 Clifton Road, NE, Atlanta, GA 30329 USA. Tel: 00 1 404 320-3333 (05 Feb 1998) |
| bladder cancer | The most common warning sign of bladder cancer is blood in the urine. The diagnosis of bladder cancer is supported by findings in the medical history and examination, blood, urine, and X-ray tests, and confirmed with a biopsy (usually during a cystoscope exam). Treatment of bladder cancer depends on the growth, size, and location of the tumour. (12 Dec 1998) |
| bladder cancer risks | Smoking is a major risk factor. Cigarette smokers develop bladder cancer 2-3 times more often than do nonsmokers. Quitting smoking reduces the risk of bladder cancer, lung cancer, several other types of cancer, and a number of other diseases as well. Workers in some occupations are at higher risk of developing bladder cancer because of exposure to carcinogens (cancer-causing substances) in the workplace. These workers include people in the rubber, chemical, and leather industries, as well as hairstylists, machinists, metal workers, printers, painters, textile workers, and truck drivers. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|